» Articles » PMID: 17217854

Treatment of Carotid Artery Disease: Stenting or Surgery

Overview
Specialty Neurology
Date 2007 Jan 16
PMID 17217854
Authors
Affiliations
Soon will be listed here.
Abstract

Carotid endarterectomy (CEA) is the only form of cerebral revascularization for which Level 1 evidence of effectiveness has been reported. Recent studies demonstrate the feasibility of carotid artery stenting (CAS) as an alternative to CEA. Its popularity is due to the perceived advantages of a less invasive treatment for carotid occlusive disease. Two randomized trials have reported no difference in the composite stroke, death, and myocardial infarction rate between CAS and CEA. However, these trials were not powered to identify superiority between the two procedures. A trial sponsored by the National Institutes of Health is currently underway to make that determination. The lead-in phase of this trial noted low complication rates with CAS. These results have encouraged the US Food and Drug Administration to approve the use of CAS in patients with neurologic symptoms (ie, ipsilateral stroke, transient ischemic attacks, and amaurosis fugax) in association with severe medical co-morbidities. Patients with carotid restenosis after previous CEA, anatomically inaccessible lesions above C2, and radiation-induced stenoses may also benefit from preferential treatment with CAS. The National Institutes of Health have now expanded the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) to include asymptomatic patients, and resulting data will help to clarify the role of CAS in this subset as well.

References
1.
. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001; 357(9270):1729-37. View

2.
Roubin G, New G, Iyer S, Vitek J, Al-Mubarak N, Liu M . Immediate and late clinical outcomes of carotid artery stenting in patients with symptomatic and asymptomatic carotid artery stenosis: a 5-year prospective analysis. Circulation. 2001; 103(4):532-7. DOI: 10.1161/01.cir.103.4.532. View

3.
Bassiouny H, Sakaguchi Y, Mikucki S, McKinsey J, Piano G, Gewertz B . Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg. 1997; 26(4):585-94. DOI: 10.1016/s0741-5214(97)70056-9. View

4.
Hobson 2nd R . CREST (Carotid Revascularization Endarterectomy versus Stent Trial): background, design, and current status. Semin Vasc Surg. 2000; 13(2):139-43. View

5.
Hobson 2nd R, Howard V, Roubin G, Brott T, Ferguson R, Popma J . Carotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg. 2004; 40(6):1106-11. DOI: 10.1016/j.jvs.2004.10.022. View